Beraprost-d3-TRK-100-d-sub-3-sub-生命科学试剂-MCE.pdfVIP

  • 3
  • 0
  • 约2.75千字
  • 约 1页
  • 2025-05-23 发布于上海
  • 举报

Beraprost-d3-TRK-100-d-sub-3-sub-生命科学试剂-MCE.pdf

Hotline:400-820-3792

Inhibitors•ScreeningLibraries•Proteins

www.MedChemE

Beraprost-d3

Cat.No.:HY-166363S

Synonyms:TRK-100-d;ML1129-d

33

分⼦式:C₂₄H₂₇D₃O₅

分⼦量:401.51

作⽤靶点:Isotope-LabeledCompounds;ProstaglandinReceptor

作⽤通路:Others;GPCR/GProtein

储存⽅式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

⽣物活性Beraprost-d3(TRK-100-d3)是氘代标记的(Rac)-Beraprost.(Rac)-Beraprost((Rac)-ML1229)是⼀种具有⼝服

活性的前列环素类似物,通过与前列环素膜受体(ProstaglandinReceptor)结合来抑制Ca2+从细胞内储存位

点释放,从⽽导致平滑肌细胞松弛和⾎管舒张。Beraprost具有促⾎管扩张,抗⾎⼩板和细胞保护作⽤,有望

⽤于⼼⾎管疾病领域研究,如⾎栓闭塞性脉管炎和闭塞性动脉硬化[1]。

体外研究Stableheavyisotopesofhydrogen,carbon,andotherelementshavebeenincorporatedintodrugmolecules,

largelyastracersforquantitationduringthedrugdevelopmentprocess.Deuterationhasgainedattention

becauseofitspotentialtoaffectthepharmacokineticandmetabolicprofilesofdrugs.

REFERENCES

[1].RussakEM,etal.ImpactofDeuteriumSubstitutiononthe

文档评论(0)

1亿VIP精品文档

相关文档